Sino Biopharmaceutical Limited (SBMFF)
OTCMKTS · Delayed Price · Currency is USD
0.9891
+0.0391 (4.12%)
At close: Aug 13, 2025
Sino Biopharmaceutical Market Cap
Sino Biopharmaceutical has a market cap or net worth of $20.44 billion as of September 9, 2025. Its market cap has increased by 166.02% in one year.
Market Cap
20.44B
Enterprise Value
21.08B
Revenue
4.27B
Ranking
n/a
PE Ratio
37.82
Stock Price
$0.99
Market Cap Chart
Since September 29, 2000, Sino Biopharmaceutical's market cap has increased from 42.32M to 20.44B, an increase of 48,195.59%. That is a compound annual growth rate of 28.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 20.44B | 172.51% |
| Dec 31, 2024 | 7.50B | -8.23% |
| Dec 29, 2023 | 8.17B | -24.55% |
| Dec 30, 2022 | 10.83B | -17.52% |
| Dec 31, 2021 | 13.13B | -27.75% |
| Dec 31, 2020 | 18.18B | 3.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 742.62M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.85M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |
| American Oncology Network | 353.52M |